NTRK2 and laryngeal carcinoma: In this study, we used gene chip technology to screen out the downstream differential genes regulated by TrkB, explored the pathways and diseases of differential gene enrichment through bioinformatics technology, and screened out key genes through the construction of a PPI network, providing a potential therapeutic target for laryngeal cancer.